A discussion of two compelling topics at this summer's Hematology-Oncology Carrier Advisory Committee Network Meeting: coverage for off-label uses of anticancer drugs and medical necessity for oral versus intravenous antiemetics.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869178 | PMC |
http://dx.doi.org/10.1200/JOP.091047 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!